Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18097 | 504 | 31.6 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BROMATOL NUTR DIETET | Address | 6 | 45% | 2% | 10 |
2 | ESTADES PRACT TUTELADES UNIT | Address | 4 | 75% | 1% | 3 |
3 | CLIN PHARMACOL MED CARE | Address | 2 | 67% | 0% | 2 |
4 | NORD PAS DE CALAIS | Author keyword | 2 | 67% | 0% | 2 |
5 | PRIMARY CARE HLTH BARTOMEU FAB ANGLADA | Address | 2 | 67% | 0% | 2 |
6 | STUDIES OBSERVAT | Address | 2 | 67% | 0% | 2 |
7 | ANTIDEPRESSANT ADHERENCE | Author keyword | 2 | 50% | 1% | 3 |
8 | CIC INSERM 0204 | Address | 2 | 43% | 1% | 3 |
9 | DRUG UTILISAT SUBCOMM | Address | 1 | 50% | 0% | 2 |
10 | LILLY MSG DEV | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRESCRIPTION DATABASE | 9 | 28% | 5% | 27 |
2 | COACHING PROGRAM | 3 | 100% | 1% | 3 |
3 | INSTRUMENTAL PLANAR CHROMATOGRAPHY | 3 | 100% | 1% | 3 |
4 | PATIENT BELIEFS | 3 | 60% | 1% | 3 |
5 | ANTIDEPRESSANT MEDICATION ADHERENCE | 2 | 67% | 0% | 2 |
6 | ANTIDEPRESSANT DRUG USE | 1 | 38% | 1% | 3 |
7 | AFFECTING NONCOMPLIANCE | 1 | 50% | 0% | 1 |
8 | IMMEDIATE RELEASE PAROXETINE | 1 | 50% | 0% | 1 |
9 | MEDICALISING UNHAPPINESS | 1 | 50% | 0% | 1 |
10 | ANTIDEPRESSANT ADHERENCE | 1 | 29% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies | 2013 | 9 | 44 | 66% |
Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review | 2012 | 10 | 23 | 43% |
Effectiveness of interventions to improve antidepressant medication adherence: a systematic review | 2011 | 27 | 65 | 29% |
Factors predicting adherence to antidepressant treatment | 2014 | 1 | 41 | 54% |
Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews | 2013 | 12 | 46 | 20% |
Improving adherence to antidepressants: A systematic review of interventions | 2003 | 87 | 36 | 25% |
A review of the costs associated with depression and treatment noncompliance: the potential benefits of online support | 2010 | 14 | 49 | 27% |
Preliminary study of patterns of medication use for depression treatment in China | 2013 | 2 | 9 | 33% |
Patient adherence in the treatment of depression | 2002 | 132 | 31 | 23% |
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants | 2010 | 23 | 27 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BROMATOL NUTR DIETET | 6 | 45% | 2.0% | 10 |
2 | ESTADES PRACT TUTELADES UNIT | 4 | 75% | 0.6% | 3 |
3 | CLIN PHARMACOL MED CARE | 2 | 67% | 0.4% | 2 |
4 | PRIMARY CARE HLTH BARTOMEU FAB ANGLADA | 2 | 67% | 0.4% | 2 |
5 | STUDIES OBSERVAT | 2 | 67% | 0.4% | 2 |
6 | CIC INSERM 0204 | 2 | 43% | 0.6% | 3 |
7 | DRUG UTILISAT SUBCOMM | 1 | 50% | 0.4% | 2 |
8 | LILLY MSG DEV | 1 | 100% | 0.4% | 2 |
9 | PHARMACOTHER Y EPIDEMIOL | 1 | 100% | 0.4% | 2 |
10 | MANAGED MARKETS | 1 | 40% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000266344 | COLLABORATIVE CARE//TREATMENT ADEQUACY//INTEGRATED PRIMARY CARE |
2 | 0.0000217592 | ACTIVATION SYNDROME//RISK EVALUATION AND MITIGATION STRATEGIES//REGULATORY ACTIONS |
3 | 0.0000110980 | MEDICATION ADHERENCE//PATIENT COMPLIANCE//MORISKY SCALE |
4 | 0.0000107736 | CHRONIC DEPRESSION//DYSTHYMIA//CBASP |
5 | 0.0000104789 | VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM |
6 | 0.0000103251 | LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM |
7 | 0.0000099124 | BLEEDING ABNORMALITIES//VENOUS THROMBOSIS AND EMBOLISM//ABORATING TRAINING PHARMACOEPIDEMIO |
8 | 0.0000099083 | MULTICULTURAL MENTAL HLTH//CLINICIAN BIAS//USMD OUTCOMES |
9 | 0.0000095277 | PALIPERIDONE PALMITATE//LONG ACTING RISPERIDONE//OLANZAPINE PAMOATE |
10 | 0.0000085929 | BENZODIAZEPINES//BENZODIAZEPINE DEPENDENCE//BENZODIAZEPINE USE |